SURUFATINIB
UNII B2K5L1L8S9

Substance Identification & Data

This profile provides standardized clinical and technical data for Surufatinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2K5L1L8S9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1308672-74-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B2K5L1L8S9

CAS Registry Number

1308672-74-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SURUFATINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H28N6O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

TTZSNFLLYPYKIL-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C116066

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

52920501

Unique identification number in the NCBI database of chemical substances.

INN ID

10349

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-176

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cc1[nH]c2c(cc(cc2)Oc3nc(Nc4cc(CS(NCCN(C)C)(=O)=O)ccc4)ncc3)c1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Surufatinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.